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Abstract
Background—We previously reported a significant association between higher ultraviolet
radiation exposure before diagnosis and greater survival with melanoma in a population-based
study in Connecticut. We sought to evaluate the hypothesis that sun exposure prior to diagnosis
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was associated with greater survival in a larger, international population-based study with more
detailed exposure information.
Methods—We conducted a multi-center, international population-based study in four countries –
Australia, Italy, Canada and the United States – with 3,578 cases of melanoma with an average of
7.4 years of follow-up. Measures of sun exposure included sunburn, intermittent exposure, hours
of holiday sun exposure, hours of water-related outdoor activities, ambient UVB dose, histological
solar elastosis and season of diagnosis.
Results—Results were not strongly supportive of the earlier hypothesis. Having had any sunburn
in one year within 10 years of diagnosis was inversely associated with survival; solar elastosis – a
measure of lifetime cumulative exposure – was not. Additionally, none of the intermittent
exposure measures – water related activities and sunny holidays - were associated with melanoma-
specific survival. Estimated ambient UVB dose was not associated with survival.
Conclusion—Although there was an apparent protective effect of sunburns within 10 years of
diagnosis, there was only weak evidence in this large, international, population-based study of
melanoma that sun exposure prior to diagnosis is associated with greater melanoma-specific
survival.
Impact—This study adds to the evidence that sun exposure prior to melanoma diagnosis has little
effect on survival with melanoma.
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INTRODUCTION
Ultraviolet radiation exposure (UVR) is the major environmental risk factor for the
development of melanoma (1) with intermittent UVR exposure, including sunburn,
generally the measure of sun exposure most strongly associated with the development of
melanoma (2–3). In a Connecticut population-based study of 650 melanoma cases followed
for an average of five years, Berwick et al. (4) reported that several measures of UVR prior
to the diagnosis of melanoma were inversely associated with mortality from melanoma,
suggesting that something about sun exposure, possibly its role in Vitamin D production,
was limiting cancer progression. Subsequently, Newton-Bishop and colleagues in a UK
study of 872 melanoma patients (5) reported that serum vitamin D levels were higher among
those with better overall survival, and Rosso and colleagues in a European study of 260
melanoma patients (6) found that melanoma patients with more sunny vacations prior to
diagnosis had better melanoma-specific survival. Laboratory studies have shown that
vitamin D suppresses tumor proliferation (7) and suggest that increased vitamin D levels
might keep a melanoma “in check”. To test the hypothesis that increased sun exposure prior
to diagnosis is associated with improved survival from melanoma, we evaluated measures of
solar UVR exposure prior to diagnosis in 3,578 incident melanoma patients in the Genes,
Environment and Melanoma study (GEM), an international, population-based study (8).
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A detailed description of the methods used in this study is available elsewhere (9). Briefly,
this multicenter, international population-based study was conducted in four countries
through eight population-based tumor registries---in Australia in the states of New South
Wales and Tasmania, in Italy in the province of Piedmont, in Canada in the provinces of
British Columbia and Ontario, and in the United States in the state of New Jersey, a 39-
county area of North Carolina, two Southern California cancer registry populations (the
Orange County Registry and the San Diego/Imperial Organization for Cancer Control), and
through a hospital-based registry in the state of Michigan.
Institutional review board approval was obtained from all centers and written informed
consent was obtained prior to interview. We interviewed 2,372 patients with incident first
primary melanoma cases and 1,206 with incident multiple primary cases. Of the 1,206 with
multiple primary cases, 96 had been first ascertained with single primaries. Single primary
melanoma cases were diagnosed in 2000 and multiple primary cases from 1998 (British
Columbia, California, New Jersey and Tasmania) or 2000 (New South Wales, North
Carolina and Ontario) to 2003.
The overall participation rate was 54 percent for individuals completing all aspects of the
study and submitting a DNA sample.
Data Collection
A structured questionnaire administered by telephone assessed basic demographics,
phenotypic characteristics, family history of cancer, recreational and occupational sun
exposure at each decade of life, sunbed use, changes in sun-related behavior after a
melanoma diagnosis, and a lifetime residential history. Nevi on the back were self-assessed
using a set of photos and by reference to charts showing different patterns of nevi and
freckles as previously described (2, 9).
UVR Exposure Measures
We evaluated effects on survival of measures of UVR exposure in various periods before
diagnosis.
Sunburns—Individuals reported whether they had been burned severely enough to have
pain or blisters for two or more days in a specified year in the 10 years before diagnosis.
This was coded as “once or more” or “never”.
Solar Elastosis—Solar elastosis, an indicator of sun exposure accumulated over a lifetime
(10), was evaluated on histopathological slide review as absent or present. Slides from 2,781
(78%) subjects were reviewed by expert dermatopathologists (LF, KB, PG) to standardize
pathologic criteria and add parameters that community pathology laboratories often do not
report, such as solar elastosis. Inter-reviewer reliability for solar elastosis was assessed as
very good (Kappa = 0.65).
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Intermittent Sun Exposure—In a previous GEM analysis, two variables were
considered to represent intermittent sun exposure – hours of holiday sun exposure in a place
sunnier than usual residence and hours of water-related outdoor activities (2). These
measures for one year in the most recent decade were categorized into quartiles based on the
distribution among the entire population and ranked from low [quartile one] to high [quartile
four].
UVB Radiation Dose—Individual residential histories were coded for latitude, longitude
and altitude from birth to age at diagnosis, and then ambient UVB irradiances calculated for
each decade of age from records of satellite measurements of irradiance at the earth’s
surface as un-weighted wavelength integrated spectral irradiance between 280 and 320 nm.
UVB was used in analyses as this wavelength is thought to be the most effective in inducing
serum vitamin D levels. Details of the calculations are available in Thomas et al. (10).
Ambient UVB levels in the decade of life that included the melanoma diagnosis, at age 10
and over the lifetime (at each decade) were multiplied by the reported time spent outdoors
on weekends and weekdays in the same period and categorized into quartiles based on the
distribution among the entire population.
Season of Diagnosis—Diagnoses were classified by season, with data pooled for
summer (December to February in the Southern hemisphere and June–August in the
Northern), autumn (March–May in the Southern hemisphere and September–November in
the Northern), winter (June–August in the Southern hemisphere and December–February in
the Northern), and spring (September–November in the Southern hemisphere and March–
May in the Northern).
Follow-up for Survival
Patient follow-up for vital status was complete through 2007 except in British Columbia and
Turin, where vital status was complete through 2008. Date and cause of death seven years
after diagnosis were obtained from National Death Indexes, cancer registries and municipal
records. We analyzed an average of 7.4 years of melanoma-specific survival. Individuals
were classified as “died of melanoma”, “died of other cause” and “alive at the end of follow
up”. An event was considered death due to melanoma. Among patients with multiple
primaries, Breslow thickness (see Supplementary Tables 1–3) and anatomic site for the
thickest of their lesions were used in statistical models.
Data Analysis
Cox proportional hazards models were used to calculate hazard ratios (HRs) and 95%
confidence intervals (CIs) for associations of categories of each exposure variable with
melanoma outcome. Time to death from melanoma from diagnosis for those with single
primaries or the most recent melanoma for those with multiple primaries was the outcome.
Those who died of other causes or who were still alive at follow up were censored in this
analysis.
Age at diagnosis, sex, recruitment center, education level, and anatomic site were potential
confounders of the association of sun exposure measures and melanoma survival. We found
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that there was no difference in effects of sun exposure measures and survival by primary
status and therefore included both single and multiple primary melanomas in analyses in
order to improve precision and included an indicator variable for primary status in all
models. Kricker et al. (11) previously reported that there was no survival difference between
multiple and single primaries in GEM. A time-dependent covariate was used for the 96
patients who developed a second primary during the study follow up period. Pigmentary
characteristics, prior history of non-melanoma skin cancer and family history of melanoma
were assessed but found not to be potential confounders of sun exposure measures in
relation to survival. Stratified analyses were conducted to determine if any effect of sun
exposure measures on risk of death from melanoma was modified by MC1R status (with or
without “red hair color” variants D84E, R151C, R160W, and D294H), ability to tan (good
and poor) and propensity to sunburn (high and low). Likelihood ratio tests for heterogeneity
were used to evaluate significance of any apparent effect modification. Tests for linear trend
were performed for ordered categorical variables. All tests were two-sided and P < 0.05 was
considered statistically significant. All data were analyzed using SAS 9.3 (Cary, NC).
RESULTS
Of the 3,578 eligible individuals diagnosed with melanoma in this study (2,007 males and
1,571 females), 563 died by the end of follow up (15.7%): 255 (7.1%) from melanoma and
308 (8.6%) from other causes.
Survival analyses are presented as baseline models, with hazard ratios adjusted for center,
age, sex, primary status and the time-dependent covariate, and as fully adjusted models,
which included the above variables as well as others significantly associated with survival:
educational level, and anatomic site.
Clinical and Host Characteristics and Melanoma-Specific Survival
Anticipated associations for host and clinical characteristics were seen (Table 1). Primary
status was not associated with hazard of death from melanoma in the fully adjusted model.
Women had a lower risk of dying from melanoma in both the baseline model (P < 0.001)
and the fully adjusted model (P = 0.0002). The hazard of death increased with increasing
age (fully adjusted HR 1.02 for each year of age, 95% CI =1.01 to 1.03, P <0.0001).
Melanomas on the arms were at lowest risk for poor survival relative to melanoma of the
head and neck (fully adjusted HR 0.47, 95% CI = 0.31 to 0.71, P = 0.003). Relative to
superficial spreading melanoma, the fully adjusted HR for lentigo maligna melanoma was
decreased (HR 0.57, 95% CI = 0.33 to 0.98, P = 0.04). Breslow thickness (fully adjusted
HR 13.79, 95% CI =9.12 to 20.84, for thickness of 4.00 mm or higher relative to thickness
of less than 1.00 mm) was strongly and significantly associated with poor prognosis (P <
0.001). Similar to most other studies, those with more education had a significantly reduced
hazard of dying from melanoma (fully adjusted HR 0.56, 95% CI = 0.40 to 0.78, P =
0.0005). Having a family history of melanoma (fully adjusted HR 0.85, 95% CI = 0.58 to
1.24, P = 0.39) or a prior history of non-melanoma skin cancer (fully adjusted HR 0.93, 95%
CI = 0.71 to 1.23, P = 0.63) did not affect the hazard of dying from melanoma.
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Recent Sun Exposure—We found a reduced HR of melanoma death with one or more
sunburns in a year in the decade before diagnosis (fully adjusted HR 0.27, 95% CI = 0.09,
0.85, P = 0.03, Table 2). Other sun exposure variables in the decade before diagnosis,
including holiday sun hours in a place sunnier than usual residence and hours of water-
related activities and estimated UVB dose, and season of diagnosis were not significantly
associated with survival from melanoma in either the baseline or the fully adjusted models.
Early Life Sun Exposure—We found a significant trend for increasing melanoma
mortality with increasing UVB dose at age 10, (fully adjusted HR 1.49, 95% CI = 0.97, 2.30,
P = 0.03) for the highest quartile compared to the lowest. Other sun exposure variables in
early life were not significantly associated with survival from melanoma (Table 3).
Lifetime Average Annual Sun Exposure—None of the lifetime cumulative or annual
average sun exposure measures were associated either positively or negatively with
melanoma-specific survival (Table 4). Solar elastosis was not associated with an increased
risk of dying from melanoma in the baseline or the fully adjusted model (HR 0.74, 95% CI
0.52, 1.07, P = 0.11). Lifetime annual average levels of holiday sun hours in a place sunnier
than usual residence, water related activities and estimated solar UVB dose were also not
significantly associated with melanoma-specific survival (Table 4).
Stratified Analyses
There was little evidence that any association of sun exposure variables and hazard of death
from melanoma varied among categories of MC1R status, ability to tan and propensity to
burn in relationship to melanoma survival (data not shown).
DISCUSSION
This study of 3,578 highly annotated patients with melanoma shows the expected
associations of host characteristics and clinical variables with survival, but provides only a
little support for our previous study in Connecticut where sun exposure prior to diagnosis
was inversely associated with melanoma survival, such that individuals with higher levels of
intermittent sun exposure, presence of solar elastosis and any sunburns prior to diagnosis
had better survival. The present study found only an inverse association of sunburns within
the 10 years prior to diagnosis with survival from melanoma. Lifetime sunburn history was
not associated with survival with melanoma, which is opposite to the finding in the
Connecticut study.
Analytic studies of sun exposure and melanoma survival are few. There are differences of
study design and study population among the several studies that show an inverse
association with either solar UVB or circulating serum vitamin D and survival compared to
the present study. Lesions were generally somewhat deeper in the Connecticut study with a
mean thickness of 1.81 mm (median 0.81 mm) versus 1.30 mm (median 0.78mm) in this
study. This difference is indicative of a general trend to diagnose thinner lesions over time
(12). The inclusion of Breslow thickness in the fully adjusted model did not materially
modify associations in models without its inclusion (Supplementary Tables 1–3). It is
important to note that because this study is population-based, it includes many individuals
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with very thin melanomas and hence high overall survival. Such population-based studies
are critical for public health recommendations, but any particular effects of lifestyle on
survival would be most relevant for the more selected group of people whose melanoma
characteristics place them at a higher likelihood of mortality from melanoma.
In the Rosso et al. (6) study, the population from Turin, Italy, was quite small. The major
variable associated with improved survival with melanoma was number of holidays to sunny
places; it is possible that this variable is confounded with socioeconomic status, which has
been found to be inversely associated with hazard of death from melanoma in three studies
(13–15).
In the Newton-Bishop et al. (5) study, measures of circulating serum vitamin D were
positively associated with relapse-free survival and lower Breslow thickness at diagnosis.
This study did not look at melanoma-specific survival, but rather overall survival.
Additionally, only individuals with tumors greater than 0.75 mm were included. These
results differ from our studies in Connecticut and the present GEM study that both focus on
melanoma-specific survival and inclusion of all tumors unrestricted by Breslow thickness.
We have evaluated overall survival, however, and found that several measures of
intermittent sun exposure prior to diagnosis—UVB dose in quartiles (P for trend = 0.004);
hours spent in water-related activities (P for trend = 0.01) and hours of holiday sun exposure
(P for trend = 0.03) --- are significantly and inversely associated with survival
(Supplementary Table 4). Our data indicate a possible impact of sun exposure on overall
survival; however, this study was not designed to evaluate deaths other than melanoma.
Several limitations deserve note, particularly the potential for misclassification in recalled
sun exposure. Because the “dose” information relies on reported hours of sun exposure
multiplied by the ambient exposure, there is the potential for misclassification that is likely
non-directional and would bias results to the null. Additionally, although sunburn is likely
subject to recall bias (16), the fact that sunburn represents overexposure to the sun, whereas
exposure to high ambient levels of UV is modified by behaviors and phenotype, may make
the single finding that sunburn prior to diagnosis is “protective” more salient. Caution is
necessary in interpreting that finding due to the very small number of deaths in the group
experiencing sunburn (n=4). Misclassification could also result from differences among
centers in non-UV sun related behaviors that might affect mortality in comparison to
previous single center studies where more uniform non-UV behaviors factors might be more
uniform.
Another concern lies with the use of death certificates for verification of mortality as death
certificates are sometimes misclassified (17). Each of the centers in this study had high
quality identification of deaths, using death certification, such as the National Death Index in
the United States and Australia and the Provincial Cancer Registries in Canada. In Italy,
deaths were verified by linking to the municipal rosters. If in fact a patient died from a
metastasis from his melanoma but was classified as dying from another cancer, such as lung
cancer, then our statistical power will have been reduced. Furthermore, it is noted that deaths
from melanoma continue to occur over a relatively long period of time, and we have
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survival information for 7.4 years, so that a longer follow up period may produce somewhat
different results.
Many studies have demonstrated positive associations between solar UV exposure at season
of diagnosis and survival from different cancers. Results are mixed although the majority of
studies demonstrate that those cancers diagnosed in the fall, when circulating serum vitamin
D levels are generally the highest, have better prognosis than those diagnosed in other
seasons. For melanoma, one study found higher survival in patients diagnosed in summer or
fall (18) and one did not (19); both were from Australia.
Our study’s strengths include the large number of participants, the variety of latitudes, the
relatively long follow up, a reliable sun exposure questionnaire (20–21), the ability to
control for confounders, and the extensive pathologic review of cases.
In conclusion, this study provides only weak evidence that high levels of sun exposure prior
to diagnosis have a benefit for melanoma survival.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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